(Q57782781)

11

Patrick Marcellin

0 references

Marie-Pierre Ripault

3

Marie-Pierre Ripault

0 references

Sarah Maylin

8

Michelle Martinot-Peignoux

Sarah Maylin

0 references

5

Michelle Martinot-Peignoux

0 references

Corinne Castelnau

1

Corinne Castelnau

0 references

Emmanuel Gordien

4

Emmanuel Gordien

0 references

Frédéric Le Gal

2

Frédéric Le Gal

0 references

author name string

Nathalie Boyer

6

0 references

Bach-Nga Pham

7

0 references

Paul Dény

10

0 references

Elyanne Gault

Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia

12

0 references

language of work or name

English

0 references

publication date

2006

0 references

published in

Hepatology

0 references

volume

44

0 references

page(s)

728-735

0 references

issue

3

0 references

cites work

1 reference

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone

21 January 2018

1 reference

Delta hepatitis: an update

21 January 2018

1 reference

7 January 2021

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

1 reference

7 January 2021

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

1 reference

7 January 2021

Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection

1 reference

7 January 2021

Treatment of hepatitis D.

1 reference

7 January 2021

Ribavirin treatment for chronic hepatitis D: a pilot study.

1 reference

7 January 2021

Lamivudine for chronic delta hepatitis

1 reference

7 January 2021

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

1 reference

7 January 2021

Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.

1 reference

7 January 2021

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Polymerase chain reaction-based detection of hepatitis D virus genome in patients infected with human immunodeficiency virus

1 reference

7 January 2021

Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction--and its possible correlation with the clinical stage of liver disease

1 reference

7 January 2021

Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients

1 reference

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

7 January 2021

Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades

1 reference

7 January 2021

Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain

1 reference

7 January 2021

Alpha interferon and ribavirin combination therapy of chronic hepatitis D.

1 reference

7 January 2021

Efficacy of pegylated interferon alpha-2b for the treatment of chronic delta hepatitis in a patient co-infected with HIV

1 reference

7 January 2021

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

1 reference

7 January 2021

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy

1 reference

7 January 2021

Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA hybridization and polymerase chain reaction

1 reference

7 January 2021

Hepatitis delta virus: the molecular basis of laboratory diagnosis

1 reference

7 January 2021

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

7 January 2021

Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection

1 reference

7 January 2021

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

1 reference

7 January 2021

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

1 reference

7 January 2021

Smouldering hepatitis B virus replication in patients with chronic liver disease and hepatitis delta virus superinfection

1 reference

7 January 2021

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections

1 reference

7 January 2021

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

1 reference

7 January 2021

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

7 January 2021